Cutler Group’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,300
Closed -$19K 4989
2018
Q3
$19K Sell
2,300
-4,900
-68% -$823K ﹤0.01% 2293
2018
Q2
$252K Sell
7,200
-3,200
-31% -$481K 0.02% 687
2018
Q1
$187K Sell
10,400
-13,300
-56% -$1.41M 0.02% 857
2017
Q4
$128K Buy
23,700
+22,100
+1,381% +$1.84M 0.01% 1234
2017
Q3
$18K Buy
1,600
+1,300
+433% +$101K ﹤0.01% 3252
2017
Q2
$4K Buy
+300
New +$16.6K ﹤0.01% 5158

Other funds holding LOXO

Cutler Group's LOXO Position: Q1 2019 in Review

Cutler Group sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 400 shares — an estimated $56K sold.

Cutler Group first reported a position in LOXO in Q2 2017 and held it in 6 quarters. The position peaked at $297K in Q3 2017. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Cutler Group reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Cutler Group sold 400 Loxo Oncology, Inc shares in Q1 2019, an estimated $56K.
  • Cutler Group first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 6 quarters.
  • Cutler Group's Loxo Oncology, Inc position peaked at $297K in Q3 2017.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Cutler Group's 13F filing for Q1 2019, filed 10 May 2019.